Exploring exciting opportunities to improve the delivery of medical devices globally.
Carrying the Company’s original name, VasoMedical is the business unit for its proprietary medical devices for noninvasive monitoring, diagnosis and treatment of certain cardiovascular disease. The engineering and production activities are mainly conducted in its China based facilities, while the marketing, sales and services are managed directly from the Company’s US and China offices or through partners in various regions of the world.
The continuing acceptance of Enhanced External Counterpulsation (EECP®) Therapy and the increased availability of EECP® Therapy Systems worldwide in hospitals, clinics and private physician practices have led to the treatment of over 300,000 patients worldwide. Complementing the EECP® product line, VasoMedical also markets a complete line of BIOXTM ECG Holter and ambulatory blood pressure monitoring products.
VasoMedical sales channels include a variety of direct and independent distributors and sales agencies around the world.